STOCK TITAN

TILRAY BRANDS INC SEC Filings

TLRY NASDAQ

Welcome to our dedicated page for TILRAY BRANDS SEC filings (Ticker: TLRY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Reading Tilray Brands SEC documents means navigating cannabis-specific fair-value accounting, multi-country licensing rules, and shifting IFRS-to-GAAP footnotes. If you have ever scrolled a 300-page annual report searching for biological asset valuations or the latest convertible-note disclosure, you know the challenge.

Our platform resolves that problem. Stock Titan delivers AI-powered summaries that turn a dense Tilray Brands annual report 10-K simplified into clear takeaways, highlights cash-flow drivers inside every Tilray Brands quarterly earnings report 10-Q filing, and flags Tilray Brands 8-K material events explained minutes after they hit EDGAR. Real-time alerts show Tilray Brands Form 4 insider transactions real-time, so you can monitor each executive purchase or sale without hunting through PDFs.

What can you extract?

  • Track harvest yields, segment margins, and goodwill impacts with one-click Tilray Brands earnings report filing analysis.
  • Receive instant notice when a director files Tilray Brands insider trading Form 4 transactions or when new equity is issued.
  • Compare compensation packages straight from the latest Tilray Brands proxy statement executive compensation section.

Whether you are understanding Tilray Brands SEC documents with AI for valuation models or following Tilray Brands executive stock transactions Form 4 before earnings, every filing is organized, searchable, and linked to expert context. Complex disclosures become actionable so you can focus on investment decisions, not document digging.

Rhea-AI Summary

Tilray Brands (Nasdaq: TLRY) filed a Form 8-K reporting a private debt-for-equity exchange completed on June 16 2025 under Item 3.02.

The company exchanged $5 million principal of its 5.20% Convertible Senior Notes due 2027 for 12,591,816 newly issued common shares. The transaction was executed with a single, unrelated holder and relied on the Securities Act Section 3(a)(9) exemption, so the shares were issued without SEC registration and no commissions were paid.

The exchange immediately reduces outstanding debt and future interest expense but increases the public float, creating potential dilution for existing shareholders. The disclosed figures imply an exchange price of roughly $0.40 per share, though the filing does not comment on market pricing.

No other material events, financial statements, legal proceedings, or risk factors were included in this report.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.14%
Tags
current report

FAQ

What is the current stock price of TILRAY BRANDS (TLRY)?

The current stock price of TILRAY BRANDS (TLRY) is $0.4007 as of June 28, 2025.

What is the market cap of TILRAY BRANDS (TLRY)?

The market cap of TILRAY BRANDS (TLRY) is approximately 366.2M.

What is Tilray Brands Inc.?

Tilray Brands Inc. is a Canadian-based company that cultivates and supplies both medical and recreational cannabis products, along with a broad portfolio of consumer packaged goods in the wellness and lifestyle segments.

How does Tilray generate revenue?

The company generates revenue through the production and export of high-quality medical cannabis to patients and healthcare institutions, alongside a diversified range of recreational cannabis and lifestyle products distributed in key international markets.

What makes Tilray different from other cannabis companies?

Tilray distinguishes itself through its GMP-certified production facilities, rigorous quality control, research-driven product development, and a diversified product portfolio that caters to both therapeutic and lifestyle needs.

Which markets does Tilray serve?

Tilray operates globally with significant market presence in Canada, Europe, Australia, Latin America, and selected parts of the United States, addressing both regulated medical cannabis exports and domestic consumer markets.

What are the core business segments of Tilray?

Tilray’s core business segments include medical cannabis production, recreational cannabis products, hemp-based food items, and cannabis-infused beverages and wellness products, all unified under a strong research and quality assurance framework.

How does Tilray ensure the quality and safety of its products?

Quality and safety are ensured by using GMP-certified production facilities and maintaining strict quality control measures throughout its research, cultivation, and production processes, aligning with high industry standards and regulatory compliance.
TILRAY BRANDS INC

NASDAQ:TLRY

TLRY Rankings

TLRY Stock Data

366.24M
1.00B
0.65%
11.72%
17.36%
Drug Manufacturers - Specialty & Generic
Medicinal Chemicals & Botanical Products
Link
Canada
NEW YORK